IDH2 and myeloid neoplasm: In the absence of these three major driver mutations, screening for other mutations associated with myeloid neoplasms, such as ASXL1, EZH2, TET2, IDH1, IDH2, SRSF2, and SF3B1, can help establish the clonal nature of the disease [5].